Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 18, 2014
Camargo Pharmaceutical Services’ Ready 4 Action
proprietary feasibility assessment enables drug developers — generic companies in particular
— to identify viable products to bring to market. Camargo will be exhibiting at the Generic
Pharmaceutical...
read more
Friday, February 07, 2014
Intelsius, a DGP company, a designer, manufacturer and distributor of temperature-controlled packaging solutions, introduced revisions to its PharmaTherm™ line of solutions to pharmaceutical industry professionals today at the 13th Annual Cool Chain ...
read more
Friday, February 07, 2014
Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio),
a biotechnology company developing DCVax® personalized immune therapies for solid tumor
cancers, announced today that it has entered into a set of agreements for large-scale expansion of
the ...
read more
Friday, February 07, 2014
SGS Life Science Services announced today the official launch of its new services for the integrated formulation and stability testing service for biologics.
read more
Friday, February 07, 2014
Dubai, United Arab Emirates, January 27, 2014 - ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Middle East clinical laboratory and diagnostics markets.
read more
Friday, February 07, 2014
PharmaCell B.V. a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe, announced today that it has entered into an agreement with TiGenix N.V. to purchase its state-of-the-art cell therapy production...
read more
Friday, February 07, 2014
AAIPharma Services, Corp. (“AAIPharma”),
a leading global provider of pharmaceutical analytical testing, product development and
manufacturing services and Cambridge Major Laboratories, Inc (“CML”), a global leader in
pharmaceutical API ...
read more
Friday, February 07, 2014
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)
(“NW Bio”), a biotechnology company developing non-toxic DCVax® personalized immune
therapies for solid tumor cancers, announced today that Dr. Marnix Bosch, Chief Technical Officer of
NW Bio, will ...
read more
Thursday, February 06, 2014
AmSafe Bridport today announced the extended, ongoing contract with Kuehne + Nagel S.a.r.l to deliver precise logistical support for the DuPont™ Tyvek® Air Cargo Thermal Cover, which AmSafe Bridport distributes to its increasing number of European ...
read more
Thursday, February 06, 2014
Almac’s Diagnostics business unit today announced the presentation of an external validation of their ColDx signature for stage II colon cancer recurrence. Following publication of the initial validation study in the Journal of Clinical Oncology (JCO...
read more
Thursday, February 06, 2014
Cytovance Biologics, Inc., a leading full-service contract manufacturer of mammalian and microbial biologics, broke ground on an expansion facility to contain both manufacturing operations and GMP warehousing. The multi-million dollar capital ...
read more
Thursday, February 06, 2014
AAIPharma Services Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and manufacturing services and Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development ...
read more
Tuesday, January 28, 2014
CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group Director of the UBM Pharma Portfolio. Central to the role is responsibility for the strategic development and delivery of market leading event brands CPhI, ...
read more
Tuesday, January 28, 2014
Johnson Matthey Catalysis and Chiral Technologies (JMCCT), a business unit of Johnson Matthey Fine Chemical Division (LSE: JMAT), has announced an expansion to its proprietary tethered catalyst technology, and is now offering multi-kilogram ...
read more
Tuesday, January 28, 2014
Ajinomoto Althea, Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today its new product offering, Corynex®, to produce secreted, soluble, ...
read more